The Phase 3 APECS trial of verubecestat stopped early. Patients on the drug declined faster than those on placebo. The drug appeared to slightly lower plaque load in the brain. Merck decided to halt ...
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that it will be stopping protocol 019, also known as the APECS study, a Phase 3 ...
State Secretary Dr. Patrick Rapp, Ministry of Economic Affairs, Labour and Tourism, hands over the symbolic cheque for the funding amount of 4.35 million euros to the institute management of ...
In this collection, Nature Reviews Earth & Environment features a series of Tools of the Trade articles (short articles on a method, instrument, or approach used in Earth and environmental science ...
* MERCK & CO INC - IT WILL BE STOPPING PROTOCOL 019, ALSO KNOWN AS APECS STUDY * MERCK & CO INC - STOPPING PROTOCOL 019, ALSO KNOWN AS APECS STUDY, A PHASE 3 STUDY EVALUATING VERUBECESTAT Source ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback